Global Frequency and Diagnosis of Hereditary Angioedema with Normal C1INH: A Real World ACARE Survey

Magerl M

ACARE Global Angioedema Forum 2024 (GAF)

Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks

Zanichelli A

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Delayed Treatment of Hereditary Angioedema Attacks on Quality of Life and Ability to Work

Yong P

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Hereditary Angioedema Attacks on Quality of Life and Ability to Work Among UK Patients Receiving Long-term Prophylaxis or On-demand Treatment Only

Savic S

ACARE Global Angioedema Forum 2024 (GAF)

The Hereditary Angioedema (HAE) Attack Journey: A Conceptual Model of Patient Anxiety and On-Demand Treatment Burden During an HAE Attack

Jones D

ACARE Global Angioedema Forum 2024 (GAF)

Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients

Valerieva A

ACARE Global Angioedema Forum 2024 (GAF)

Phase 3 KONFIDENT Trial of Oral Sebetralstat for Treatment of Hereditary Angioedema Attacks: Analysis of the European and US Patient Subgroups

Zanichelli A

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial

Maurer M

ACARE Global Angioedema Forum 2024 (GAF)

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Guilarte M

ACARE Global Angioedema Forum 2024 (GAF)

KONFIDENT-S Interim Analysis: Sebetralstat for Hereditary Angioedema Attacks (Including Laryngeal)

Farkas H

Bradykinin Symposium 2024